Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Surgery. 2012 Apr;151(4):526-36. doi: 10.1016/j.surg.2011.12.002. Epub 2012 Jan 11.
During resection of a hepatocellular carcinoma, surgeons encounter occasionally a situation where marginal resection is inevitable because of a close association between the hepatocellular carcinoma and major vasculature and/or underlying impaired liver function. We investigated the impact of marginal resection on recurrence-free survival after a resection of a solitary hepatocellular carcinoma.
The data of 570 patients who underwent macroscopically curative hepatectomy for a solitary hepatocellular carcinoma in our institution between 1990 and 2007 were analyzed. Marginal resection and non-marginal resection were defined as a cancer-negative surgical margin of ≤ 1 mm and a surgical margin of >1 mm, respectively. The macroscopic appearance of the hepatocellular carcinoma was classified as the simple nodular type or non-simple nodular type based on the classification of the Liver Cancer Study Group of Japan, and patients were categorized into 4 groups: group A, simple nodular type with cirrhosis; group B, simple nodular type without cirrhosis; group C, non-simple nodular type with cirrhosis; and group D, non-simple nodular type without cirrhosis.
The surgical margins were diagnosed as cancer-positive in 31 patients, as marginal resection in 165 patients, and as non-marginal resection in 374 patients. The marginal resection group showed a better recurrence-free survival than the positive surgical margin group (P = .001), and also a worse recurrence-free survival than the non-marginal resection group (P = .003). In groups A, B, and C, the recurrence-free survival rates were similar between marginal resection and non-marginal resection patients (P = .458), while in group D, marginal resection was a significant poor prognostic factor of recurrence-free survival in both univariate and multivariate analyses.
Marginal resection is acceptable in group A, B, and C patients, because it did not negatively affect postoperative recurrence-free survival.
在肝细胞癌切除术中,由于肝癌与大血管和/或基础肝功能受损之间的密切关系,有时不可避免地需要进行边缘性切除。我们研究了边缘性切除对我院 1990 年至 2007 年间行根治性肝切除术的单发肝细胞癌患者无复发生存的影响。
分析了我院 570 例单发肝细胞癌患者的资料,这些患者均接受了根治性肝切除术。边缘性切除和非边缘性切除定义为癌切缘≤1mm 和癌切缘>1mm。根据日本肝癌研究组的分类,将肝细胞癌的大体外观分为单纯结节型或非单纯结节型,并将患者分为 4 组:A 组,单纯结节型合并肝硬化;B 组,单纯结节型不合并肝硬化;C 组,非单纯结节型合并肝硬化;D 组,非单纯结节型不合并肝硬化。
31 例手术切缘诊断为阳性,165 例为边缘性切除,374 例为非边缘性切除。边缘性切除组的无复发生存率优于阳性切缘组(P=0.001),也差于非边缘性切除组(P=0.003)。在 A、B 和 C 组中,边缘性切除组和非边缘性切除组的无复发生存率无差异(P=0.458),而在 D 组,边缘性切除是影响无复发生存率的独立预后不良因素。
在 A、B 和 C 组患者中,边缘性切除是可以接受的,因为它不会对术后无复发生存产生负面影响。